Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients
Background: Research over the past decade has focused on the role of Klotho as a cardio protective agent that prevents the effects of aging on the heart and reduces the burden of cardiovascular disease CVD. The role of the interaction between fibroblast growth factor 23-(FGF-23)/Klotho in Klotho-med...
Main Authors: | Ana Paula Silva, Filipa Mendes, Eduarda Carias, Rui Baptista Gonçalves, André Fragoso, Carolina Dias, Nelson Tavares, Hugo Mendonça Café, Nélio Santos, Fátima Rato, Pedro Leão Neves, Edgar Almeida |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/7/1536 |
Similar Items
-
Skeletal manifestations in end-stage renal disease patients and relation to FGF23 and Klotho
by: TOMŞA Anamaria Magdalena, et al.
Published: (2020-09-01) -
FGF-23, Klotho and Vitamin D Levels in Scleroderma
by: Ravan AHMADI, et al.
Published: (2017-04-01) -
Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications
by: Laura Salanova Villanueva, et al.
Published: (2016-07-01) -
Osteocytic FGF23 and Its Kidney Function
by: Rafiou Agoro, et al.
Published: (2020-08-01) -
Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease
by: Juan Rafael Muñoz-Castañeda, et al.
Published: (2020-03-01)